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Abstract
The Salvador-Warts-Hippo (SWH) pathway is an important regulator of tissue growth that is frequently subverted in human
cancer. The key oncoprotein of the SWH pathway is the transcriptional co-activator, Yes-associated protein (YAP). YAP
promotes tissue growth and transformation of cultured cells by interacting with transcriptional regulatory proteins via its
WW domains, or, in the case of the TEAD1-4 transcription factors, an N-terminal binding domain. YAP possesses a putative
transactivation domain in its C-terminus that is necessary to stimulate transcription factors in vitro, but its requirement for
YAP function has not been investigated in detail. Interestingly, whilst the WW domains and TEAD-binding domain are highly
conserved in the Drosophila melanogaster YAP orthologue, Yorkie, the majority of the C-terminal region of YAP is not
present in Yorkie. To investigate this apparent conundrum, we assessed the functional roles of the YAP and Yorkie C-termini.
We found that these regions were not required for Yorkie’s ability to drive tissue growth in vivo, or YAP’s ability to promote
anchorage-independent growth or resistance to contact inhibition. However, the YAP transactivation domain was required
for YAP’s ability to induce cell migration and invasion. Moreover, a role for the YAP transactivation domain in cell
transformation was uncovered when the YAP WW domains were mutated together with the transactivation domain. This
shows that YAP can promote cell transformation in a flexible manner, presumably by contacting transcriptional regulatory
proteins either via its WW domains or its transactivation domain.
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Introduction
The Yes-associated protein (YAP) is a transcription co-activator
that mediates the transcriptional output of the Salvador/Warts/
Hippo (SWH) pathway, which is a tumour suppressor pathway
that was first identified in Drosophila melanogaster [1]. The SWH
pathway restricts organ size in D. melanogaster and mammals, and
deregulation of the pathway leads to egregious organ overgrowth
[2,3,4]. In D. melanogaster, core components of the SWH pathway
include the scaffold proteins, Salvador (Sav) and Mob as tumor
suppressor (Mats), and the S/T kinases, Warts (Wts) and Hippo
(Hpo). These proteins limit organ growth by phosphorylation-
mediated inhibition of Yorkie (Yki), which is homologous to YAP
in mammals [5]. In mammals, LATS1 and LATS2 (the homologs
of D. melanogaster Wts) phosphorylate YAP on five sites, of which
S127 and S381 appear to be the most important [6,7]. S127
phosphorylated YAP partitions more readily to the cytoplasm
through binding with 14-3-3 proteins [6,7], while S381 phosphor-
ylation leads to YAP destabilization through ubiquitin-mediated
degradation [8]. Upstream of the core kinase cassette, an
increasing number of proteins, many of which reside at cell
junctions, have been shown to regulate SWH pathway activity [9].
Following the discovery that Yki promotes the growth of D.
melanogaster tissues, several points of evidence have shown that YAP
has oncogenic potential in mammals. Overexpression of YAP can
confer anchorage-independent growth of NIH3T3 or MCF10A
cells and can stimulate growth-factor independent growth,
migration and invasion of MCF10A cells, which are hallmark
properties of oncogenes [10,11,12]. In transgenic mice, YAP
overexpression in liver, gastrointestinal tract and skin induces
hyperplasia [6,13,14], whilst the YAP gene was found to be
amplified in mouse models of breast and liver cancer [10,15]. In
addition, YAP protein is elevated and more nuclear at a high
frequency in several types of human cancer, and increased nuclear
YAP correlates with poor patient outcome in tumors such as
ovarian, liver and lung [16,17,18,19].
Although the mechanism of YAP-induced oncogenesis is not
fully understood, several studies have suggested that the TEAD1-4
transcription factors are major mediators of YAP’s growth-
promoting ability. YAP activates TEAD1-4 and stimulates
transcription of known TEAD1-4 target genes [20,21]. In
addition, gene-profiling studies showed a large degree of overlap
of genes induced by overexpression of murine YAP or constitu-
tively active TEAD2 [22]. The association between YAP and
TEAD1-4 is mediated by the N-terminus of YAP and the C-
termini of TEAD1-4 [21]. Reducing the expression of TEAD1-4,
or destroying the interaction between YAP and TEAD1-4, blocks
YAP-induced cell transformation [20]. Similarly, in D. melanogaster,
the sole TEAD1-4 homologue, Scalloped (Sd), interacts with Yki
and is required for Yki-induced tissue overgrowth [23,24,25]
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terminus, YAP possesses several other conserved protein domains.
It harbors two WW domains that mediate interactions with
important regulatory proteins that either promote or inhibit YAP’s
ability to drive transcription and promote cell transformation,
migration and epithelial to mesenchymal transition in a cell- and
context-dependent fashion [11,12,26]. YAP also possesses binding
motifs for SH3- and PDZ-domains, as well as a putative
transactivation (TA) domain in its C-terminus [27,28]. The TA
domain was first identified based on its ability to transactivate the
minimal Gal4 DNA-binding domain as well as the pEBP2a
transcription factor [29], although its relationship to YAP’s
biological functions has never before been studied. Interestingly,
homology between the C-termini of Yki and YAP is very low and
they vary greatly in length; following the second WW domain, Yki
contains a further 55 amino acids, whereas YAP contains 226–242
amino acids, depending on the splice variant. This low homology
is in direct contrast to other regions of Yki and YAP, e.g. the WW
domains, Sd/TEAD-binding domain and LATS/Wts phosphor-
ylation sites, that are highly conserved [30,31].
Therefore, we sought to investigate the requirement of the TA
domain for YAP’s ability to stimulate cell proliferation, migration,
invasion and oncogenic transformation, as well as the C-terminus
of Yki for its ability to stimulate tissue growth in vivo. Surprisingly,
we found that the TA domain was dispensable for YAP-mediated
transformation and proliferation. By contrast, this domain was
required for YAP to stimulate cell migration and invasion. These
results question an obligate requirement for the putative TA
domain for YAP’s ability to act as a transcriptional co-activator
protein.
Materials and Methods
Drosophila melanogaster strains
Transgenic flies harbouring the UAS-yki or UAS-ykiDC trans-
genes (represented schematically in Figure 1) were generated by
phiC31-mediated targeted insertion into the VIE-260E site on
chromosome 2L. Other were strains were: GMR-Gal4, 71B-Gal4,
ex
697, yki
B5 [5] y w, hsFLP, UAS-CD8-GFP; tub-Gal4, FRT42D, tub-
Gal80 [32]. D. melanogaster genotypes by Figure panel:
Figure 2a) w; UAS-GFP/+; GMR-Gal4/+
Figure 2b) w; UAS-Yki/+; GMR-Gal4/+
Figure 2c) w; UAS- YkiDC/+; GMR-Gal4/+
Figure 2d) w; UAS-GFP/+; 71B-Gal4/+
Figure 2e) w; UAS-Yki/+; 71B-Gal4/+
Figure 2f) w; UAS- YkiDC/+; 71B-Gal4/+
Figure 2h) w; en-Gal4, UAS-GFP/UAS-Yki
Figure 2i) w; en-Gal4, UAS-GFP/UAS-YkiDC
Figure 2j) w, hsFLP, UAS-CD8-GFP; tub-Gal4, FRT42D, tub-
Gal80/FRT42D, yki
B5
Figure 2k) w, hsFLP, UAS-CD8-GFP; tub-Gal4, FRT42D, tub-
Gal80/UAS-Yki, FRT42D, yki
B5
Figure 2i) w, hsFLP, UAS-CD8-GFP; tub-Gal4, FRT42D, tub-
Gal80/UAS- YkiDC, FRT42D, yki
B5
Wing size measurements
Wings of male flies were mounted in Canada Balsam (Sigma)
and imaged on an Olympus BX-51 microscope. Wing size was
quantified using Adobe Photoshop CS3 as in [33]. Microsoft Excel
was used for statistical analysis (two-sample students T-test
assuming unequal variance).
Figure 1. Schematic illustration of wild-type and mutant Yorkie and YAP proteins. Wild-type Yki is 418 amino acids long, whereas Yki-DC
lacks the final 51 amino acids at the C-terminus. YAP2L is 504 amino acids long and contains two WW domains, as well as three domains in its C-
terminus: an SH3 binding domain, a transactivation domain (TA) and a PDZ-binding motif. In YAP-DC, the C-terminus of YAP is deleted. In YAP-DTA,
the TA domain is deleted. These deletions were generated in wild-type YAP2L, as well as in YAP2L-S127A, which contains a single amino acid
mutation of S127 to A. In YAP-S127A-DTA-S94A, S94 is also mutated to A. YAP-WW1+2* includes W199F and P202A mutations in WW domain 1 and
W258F and P261A mutations in WW domain 2. In YAP-WW1+2*-DTA, the WW domains are mutated as above and the TA domain is deleted.
doi:10.1371/journal.pone.0031994.g001
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Imaginal wing discs were stained as described [34], using mouse
anti-b-Galactosidase (1:200; Sigma) and goat anti-mouse 555
(1:600; Molecular Probes, Invitrogen). Images were recorded on
an Olympus FV-1000 microscope and processed using Adobe
Photoshop CS3. yki
B5 mutant clones (with and without UAS-yki
transgene expression) were generated by a 15 min heat shock
72 hrs after egg deposition and were dissected 49 hrs later.
Mammalian cell culture and analysis
MCF10A and NIH-3T3 cell transfection and infection were
performed as described previously [11,35]. Protein expression was
determined by immunoblotting with anti-Flag (Sigma) and anti-
Actin (Cell Signaling) antibodies. Two-dimensional culture of
NIH-3T3 cells, three-dimensional culture of MCF10A cells, soft
agar, cell proliferation, migration and invasion assays were
performed using published protocols [11,35].
Expression constructs
YAP-S127A, YAP-WW1+2* and YAP-S94A mutations were
described previously [11]. DCa n dDTA mutations were generated in
either YAP2L or YAP2L-S127A by PCR amplification and cloned
into pBabe. Yki-DC was generated by PCR and cloned into PKC26.
All plasmids were verified by sequencing. Primer sequences were:
Figure 2. The carboxyl terminus of Yorkie is dispensable for its ability to stimulate tissue growth in D. melanogaster. (a–c) Dorsal views
of fly heads expressing the indicated transgenes with the eye-specific GMR-Gal4 driver. (d–f) Wings of flies expressing the indicated transgenes using
the 71B-Gal4 driver. (g) Quantification of wing sizes of genotypes displayed in (d–f). Data is presented as mean +/2 SD, n=20 for each genotype, ***
indicates p,0.0001. (h and i) Expression of Yki (h) and Yki-DC (i) in the posterior compartment of the developing wing (marked by GFP, green) with
the en-Gal4 driver resulted in upregulation of ex-lacZ (grayscale in single channel, red in overlay). (j–l) yki
B5 mutant clones alone or co-expressing a yki
transgene in wing discs, marked by GFP (green). Nuclei of cells are marked with DAPI (blue). (j) yki
B5 mutant clones. (k) yki
B5 mutant clones co-
expressing Yki. (l) yki
B5 mutant clones co-expressing YkiDC.
doi:10.1371/journal.pone.0031994.g002
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GACGACAAGATGGACCCCGGGCAGCAG
YAP-DC-R: CCGAATTCCTAAGCACTCTGACTGATTCTC
YAP-DTA-R: CCGAATTCCTATAACCATGTAAGAAAG-
CTTTCTGGGCTCTGGGGAGCCAG
CCGAATTCCTATAACCATGTAAGAAAGCTTTCAGCA-
CTCTGACTGATTCTC
Yki-Myc-F: CCGAATTCATGGAACAAAAACTCATCTCA-
GAAGAGGATCTGTGCGCGTGCCTAATC
Yki- DC-R: CCTCTAGATTATTGCATTCTGGGATCATTCC
Results
The carboxyl terminus of Yorkie is dispensable for its
ability to stimulate tissue growth in Drosophila
melanogaster
Homologues of YAP are present in many species from
holozoans to humans [30,31]. Among the most conserved domains
in YAP homologues are the WW domains, the N-terminal TEAD-
binding domain and regions of the C-terminus [30,31], which
have been posited to constitute YAP’s transactivation domain [29].
Surprisingly, whilst D. melanogaster Yki displays strong conservation
of the WW and TEAD-binding domains, it is bereft of the
majority of C-terminal sequences found in YAP and has only 55
amino acids following the second WW domain compared with 242
amino acids in YAP2L. Despite this, it is still formally possible that
the shorter Yki C-terminus possesses the ability to regulate
transcription factor activity and tissue growth.
To investigate this possibility, we generated two UAS-inducible
yki transgenes; one encoding a full length Yki protein and one
encoding a Yki protein lacking the last 51 amino acids (Yki-DC)
(Figure 1). Each transgene was inserted into the same genomic
locus on chromosome II to ensure comparable overexpression.
When overexpressed in the developing D. melanogaster eye using
GMR-Gal4, each transgene caused strong overgrowth (Figures 2a–
c). To verify these findings in another tissue, each transgene was
overexpressed in the developing wing using 71B-Gal4. Overex-
pression of UAS-Yki or UAS-Yki-DC increased wing size relative to
the control by 16.2% and 9.9%, respectively, showing that each
transgene caused tissue overgrowth in a different tissue type
(Figures 2d–g). Yki drives expression of genes such as DIAP1 and
expanded (ex). To determine whether the C-terminus of Yki was
required for Yki to regulate ex transcription, we assessed ex levels
using a lacZ enhancer-trap in the ex locus in the posterior
Figure 3. YAP does not require its transactivation domain to transform cells. (a and b) Quantitation of the number of colonies expressing
vector alone (CON) or the indicated YAP plasmids in MCF10A (a) or NIH-3T3 (b) cells grown in soft agar. (c) Representative pictures of soft agar assays
from (b). (d) Quantitation of the size of colonies expressing the indicated plasmids in NIH-3T3 cells grown in soft agar. Data in a, b and d are
presented as mean +/2 SD, n=3.
doi:10.1371/journal.pone.0031994.g003
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lacZ levels were elevated to similar degrees, showing that Yki does
not require its C-terminus to regulate transcription from the ex
locus (Figures 2h–i9). Finally, we investigated the ability of yki-DC
to overcome growth and survival deficiencies associated with yki
loss of function clones [5] by expressing each transgene in yki
B5
clones using the MARCM technique [32]. Both the yki and yki-DC
transgenes rescued the size of yki clones to similar degrees
(Figures 2j–l). Collectively, this data conclusively demonstrates that
Yki does not require is C-terminus to promote tissue growth and
survival, or transcription of a well-characterized Yki target gene.
YAP does not require its transactivation domain to
transform cells
The ability to induce anchorage-independent cell growth is a
hallmark of oncogenes; this includes YAP, which has been shown
to promote anchorage-independent growth of both MCF10A and
NIH-3T3 cells [10,11,12,36]. To investigate the functional role of
the YAP C-terminus, we first sought to determine whether it is
required for YAP to induce anchorage-independent growth. All of
the following experiments were performed with YAP2L or
derivatives of the YAP2L gene, but for simplicity, are referred to
as YAP. Two mutants lacking either the entire C-terminal domain
following the second WW domain, YAP-DC (deletion of residues
278 to 504 in YAP2L), or the region previously defined as the YAP
transactivation domain [29], YAP-DTA (deletion of residues 291
to 497 in YAP2L), were constructed in either wild type YAP2L or
in YAP2L-S127A, a hyperactive YAP where the major LATS1/
LATS2 phosphorylation site has been mutated from S to A
(Figure 1). Stably infected MCF10A or NIH-3T3 cells were
generated that exhibited robust expression of wild type YAP or
mutant YAP proteins (Figure S1).
To assess the ability of different YAP mutants to confer
anchorage-independent cell growth, each cell line was plated in
soft agar assay and incubated for 7 (NIH-3T3) or 14 (MCF10A)
days. Consistent with previous reports, YAP induced robust colony
growth in soft agar compared with the vector control. By contrast,
YAP-DC failed to induce growth in soft agar (Figure 3a). Similarly,
YAP-S127A-DC induced minimal colony growth in soft agar
compared to YAP-S127A (Figure 3a). Unexpectedly, we observed
no significant difference in colony number between cells
expressing either YAP-DTA or YAP. In addition, YAP-S127A-
DTA stimulated growth of a greater number of colonies in soft
agar than YAP-S127A (Figure 3a). Similar results were obtained
when the described YAP proteins were expressed in NIH-3T3 cells
with respect to colony number in soft agar, however colony size
was reduced in cells expressing YAP-S127A-DTA compared with
YAP-S127A (Figures 3b–d). These results show that, unexpectedly,
the YAP TA domain is not required for its ability to induce
anchorage-independent growth and instead implicate the TA
domain in mediating negative regulation of YAP activity.
Transactivation domain-deficient YAP requires TEAD
transcription factors to transform cells
TEAD1-4 transcription factors are major effectors of the oncogenic
activity of YAP [20]. Therefore, we sought to determine whether
YAP-DTA and YAP-S127A-DTA-mediated cell transformation was
reliant on TEAD transcription factors. Given that S94 of YAP
mediates interaction with TEAD1-4 and mutation of S94 to A
abolishes YAP’s transformation potential [20], we investigated
whether S94 was also required for YAP-DTA to transform cells.
Stably transfected MCF10A and NIH-3T3 cells were generated that
expressed YAP-S127A-DTA-S94A. When these cell lines were plated
in soft agar, the S94A mutation was found to almost completely revert
the ability of YAP-DTA to induce growth in soft agar of both
MCF10A cells (Figure 4a) and NIH-3T3 cells (Figure 4b). These
results show that, despite the deletion of the TA domain, YAP retains
the ability to transform cells in a TEAD-dependent fashion.
YAP-mediated cell transformation requires either the WW
domains or its transactivation domain
Previously, we discovered that the WW domains of YAP and its
D. melanogaster orthologue, Yki, played cell-specific roles with
respect to induction of cell transformation and tissue growth,
Figure 4. Hyperactivated YAP requires WW domains and TEAD transcription factors to stimulate cell transformation. Quantitation of
number of colonies expressing vector alone (CON) or the indicated YAP plasmids in MCF10A cells (a) or NIH-3T3 cells (b). Data is presented as mean
+/2 SD, n=3.
doi:10.1371/journal.pone.0031994.g004
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the ability of YAP to transform MCF10A cells, but reduced YAP’s
ability to transform NIH-3T3 cells. WW domain mutations also
blocked Yki’s ability to stimulate tissue growth [11]. These results
suggested that the YAP/Yki WW domains interact with a
protein(s) that is required for its ability to promote gene
transcription in a cell-specific manner. Based on these earlier
findings and our discovery that in MCF10A cells the TA domain
of YAP is not required to induce growth in soft agar, we
hypothesized that YAP activates transcription factors either by its
TA domain or by proteins that interact with its WW domains.
Therefore, we reasoned that mutation of both the TA domain and
the WW domains would render YAP unable to transform
MCF10A cells. Consistent with previous results, WW domain
mutant YAP (YAP-WW1+2*) induced growth in soft agar with
similar potency as YAP-S127A (Figure 4a) [11]. Deletion of the
TA domain increased the ability of YAP-S127A to induce growth
in soft agar even further. By contrast, when both the WW domains
were mutated and the TA domain was deleted (YAP-WW1+2*-
DTA), YAP’s transforming potential was abolished (Figure 4a).
This shows that in MCF10A cells, YAP can tolerate mutation of
either the WW domains or the TA domain and in fact, each of
these mutations alone causes YAP hyperactivation. However, YAP
requires at least one of these domains to be intact to transform
cells, which suggests inherent flexibility in YAP’s ability to
transform cells and activate TEAD transcription factors.
The transactivation domain is not required for YAP to
promote cell proliferation
In previous studies, YAP was shown to enhance the prolifer-
ation rate of both NIH-3T3 cells grown in a two-dimensional (2D)
culture, as well as MCF10A cell colony size grown in a three
dimensional (3D) matrigel assay [11,12,22]. To investigate the role
of different YAP protein domains for YAP’s ability to increase
proliferation rates, we assessed NIH-3T3 cells expressing different
YAP variants plated in 0.5% serum. As shown in Figure 5a, the
proliferation curve of stably infected NIH-3T3 cell lines could be
Figure 5. YAP’s transactivation domain is dispensable for its ability to stimulate cell proliferation. (a) Proliferation rate of NIH-3T3 cells
expressing vector alone (CON) or the indicated YAP plasmids when cultured in medium containing 0.5% serum. (b) Quantitation of the number of
colonies expressing vector alone (CON) or the indicated YAP plasmids in MCF10A cells grown in soft agar for 14 days. Data in (a) and (b) is presented
as mean +/2 SD, n=3. (c) Representative pictures of acini of MCF10A cells quantified in (b).
doi:10.1371/journal.pone.0031994.g005
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both exhibited increased proliferation rates, whereas YAP-DC and
YAP-S127A-DTA-S94A proliferated at a similar rate as vector
control cells, and began to die after three days in 0.5% serum
medium. This shows that deletion of the TA hyperactivates, rather
than impedes, YAP’s ability to increase rates of NIH-3T3 cell
proliferation in low serum medium.
In addition, we assessed the size of acini formed by MCF10A
cells that expressed different YAP variants, in 3D matrigel. As
shown in Figures 5b and c, acini were larger when cells expressed
YAP-S127A compared with vector control cells. However,
additional deletion of the C-terminus reduced acini size of cells
expressing YAP-S127A-DC, showing that the YAP C-terminus is
required for this phenotype. Acini formed by cells expressing YAP-
S127A-DTA were even larger than cells expressing YAP-S127A,
further enforcing that the TA domain normally inhibits YAP
function, consistent with our earlier results. In addition, the ability
of YAP-S127A-DTA to stimulate MCF10A cell acini size was
dependent on TEAD transcription factors, as introduction of the
S94A mutation into YAP-S127A-DTA substantially reduced acini
size (Figures 5b and c).
The transactivation domain is essential for YAP to
stimulate cell migration and invasion
To investigate the role of the TA domain of YAP in other
functional settings, we assessed the ability of each YAP mutant to
promote invasive growth in a 3D matrigel assay. Consistent with
previous reports, overexpression of YAP-S127A in MCF10A cells
cultured in matrigel caused spike-like protrusions, which is defined
as an invasive phenotype [data not shown and [11]]. The number
of invasive acini in matrigel was almost completely abolished in
each of the YAP mutants (Figure 6a). We also assessed the ability
of each YAP mutant to promote cell migration in a two-
dimensional scratch assay. Cells were grown to confluence,
scratched with a pipette tip and wound closure assessed 24 hours
later. Cells expressing each mutant version of YAP migrated far
less efficiently than cells expressing YAP-S127A, which exhibited
enhanced migratory properties, consistent with our previous
findings (Figure 6b) [11]. Taken together, these results show that
the TA domain is required for YAP’s ability to stimulate MCF10A
cell invasion and migration, which contrasts with the requirement
of this domain for anchorage-independent growth, colony growth
and proliferation in low-serum media.
Discussion
The Yorkie and YAP transcriptional co-activator proteins are
conserved regulators of tissue growth in flies and mammals,
respectively. Given the high degree of functional conservation
between these proteins and the mechanism by which they are
regulated, we were intrigued by the lack of conservation in the C-
termini of these proteins, particularly because the C-terminus of
YAP contains a transactivation domain that is necessary for its
ability to activate transcription factors in vitro [29]. To investigate
this apparent conundrum, we generated various YAP and Yki
mutant proteins and assessed their activity using an array of
functional assays.
Based on the previous finding that YAP possessed a potent TA
domain that was required for YAP to activate the pEBP2a
transcription factor [29], we predicted that it would be required
for YAP to transform cells. Surprisingly, this was not the case as we
found the TA domain to be dispensable for YAP’s ability to induce
transformation and proliferation of cells. In fact, this version of
YAP displayed increased activity, pointing to the existence of YAP
inhibitors that act via this domain. One such candidate is LATS1/
2, which phosphorylates YAP S381 and primes it for ubiquitin-
mediated degradation [8], although other inhibitors might also act
via the TA domain.
By contrast, the TA domain was required for YAP to stimulate
cell migration and invasive properties in cells cultured in 3D. This
suggests that the YAP TA domain has context-specific roles: it is
Figure 6. YAP requires its transactivation domain to promote cell migration and invasion. (a) Quantitation of acini with invasive
protrusions in MCF10A cells expressing vector alone (CON) or the indicated YAP plasmids. (b) Quantitation of enclosed area after a scratch was
introduced for 20 hours in confluent MCF10A cells expressing vector alone (CON) or the indicated YAP plasmids. Data are presented as mean +/2 SD,
n=3.
doi:10.1371/journal.pone.0031994.g006
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behaviour, but not proliferation and survival. We previously
observed a similar relationship when studying WW domain
mutant versions of YAP in NIH-3T3 cells. A hyperactive version
of YAP required its WW domains to stimulate cell migration, but
not to promote growth in soft agar [11]. Alternatively, YAP might
require different activity thresholds to regulate transcription of
different classes of genes: e.g. a low threshold for genes that control
cell survival and proliferation, and a high threshold for genes that
control cell migration and invasion. The absence of the TA
domain in Yki, might explain why, at least to date, Yki has not
been found to regulate cell migration or motility in D. melanogaster.
Interestingly, when either the WW domains or TA domain were
mutated, YAP’s transformation potential increased substantially,
but when both domains were mutated, YAP activity was lost. This
suggests that YAP is a flexible transcription co-activator and that it
can regulate transcription of genes that transform cells by
complexing with proteins either through its WW domain or its
TA domain. In either scenario, we found that YAP stimulates
transformation via TEAD transcription factors. Our finding that
the TA domain is not required to mediate transformation via
TEAD transcription factors is supported by our study of Yki. The
WW domains and the TEAD-binding domain are conserved
between Yki and YAP, but the Yki and YAP C-termini are poorly
conserved. The fact that a Yki protein that lacked the C-terminus
could rescue loss of the wild-type protein shows that Yki activates
its partner transcription factors independently of its C-terminus.
Based on several recent studies, Yki most likely interacts with
transcriptional regulatory proteins via its WW domains [37,38].
This mechanism appears to have been conserved in mammalian
YAP, with an additional layer of complexity, whereby YAP can
promote transcription by interacting with proteins either via its
WW domains or the TA domain.
The SWH pathway has been reported to be frequently
subverted in human cancer, largely based on the observation that
YAP is localized to the nucleus in a high percentage of solid
tumours. Based on these findings and YAP’s potent pro-tissue
growth and pro-transformation activity, it has been touted as a
candidate for therapeutic intervention. This study highlights a
remarkable degree of complexity in both the regulation of YAP
activity and the mechanism by which YAP regulates gene
transcription. It also suggests redundant mechanisms by which
YAP can regulate expression of genes that promote cell
transformation, and that the same YAP domains mediate both
positive and negative regulatory interactions. Therefore, great care
will be required when designing therapies aimed at disabling YAP
function in transformed cells.
Supporting Information
Figure S1 Expression of wild-type and mutant YAP
proteins in MCF10A and NIH-3T3 cells. Expression levels
of YAP in cells stably expressing vector alone (CON) or various
YAP proteins in either MCF10A or NIH-3T3 cells. Actin levels
were determined to ensure even loading. Molecular mass markers
in kDa are shown on the left.
(TIFF)
Acknowledgments
We thank C. Poon for comments and D. Haber, L. Luo, D. Pan, the
Vienna Drosophila RNAi Center, the Australian Drosophila Research
Support Facility (www.ozdros.com) and the Bloomington Stock Centre for
plasmids and fly stocks.
Author Contributions
Conceived and designed the experiments: XZ FAG KFH. Performed the
experiments: XZ FAG KFH. Analyzed the data: XZ FAG KFH. Wrote
the paper: XZ FAG KFH.
References
1. Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, et al. (2002) salvador
Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in
human cancer cell lines. Cell 110: 467–478.
2. Harvey K, Tapon N (2007) The Salvador-Warts-Hippo pathway - an emerging
tumour-suppressor network. Nat Rev Cancer 7: 182–191.
3. Halder G, Johnson RL (2011) Hippo signaling: growth control and beyond.
Development 138: 9–22.
4. Pan D (2010) The hippo signaling pathway in development and cancer. Dev Cell
19: 491–505.
5. Huang J, Wu S, Barrera J, Matthews K, Pan D (2005) The Hippo signaling
pathway coordinately regulates cell proliferation and apoptosis by inactivating
Yorkie, the Drosophila Homolog of YAP. Cell 122: 421–434.
6. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a
universal size-control mechanism in Drosophila and mammals. Cell 130:
1120–1133.
7. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact inhibition and
tissue growth control. Genes Dev 21: 2747–2761.
8. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL (2010) A coordinated
phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-
TRCP). Genes Dev 24: 72–85.
9. Grusche FA, Richardson HE, Harvey KF (2010) Upstream regulation of the
hippo size control pathway. Curr Biol 20: R574–582.
10. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, et al. (2006) Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.
Proc Natl Acad Sci U S A 103: 12405–12410.
11. Zhang X, Milton CC, Humbert PO, Harvey KF (2009) Transcriptional output
of the Salvador/warts/hippo pathway is controlled in distinct fashions in
Drosophila melanogaster and mammalian cell lines. Cancer Res 69: 6033–6041.
12. Zhao B, Kim J, Ye X, Lai ZC, Guan KL (2009) Both TEAD-binding and WW
domains are required for the growth stimulation and oncogenic transformation
activity of yes-associated protein. Cancer Res 69: 1089–1098.
13. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1
increases organ size and expands undifferentiated progenitor cells. Curr Biol 17:
2054–2060.
14. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, et al. (2011)
Yap1 Acts Downstream of alpha-Catenin to Control Epidermal Proliferation.
Cell 144: 782–795.
15. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, et al. (2006)
Identification and validation of oncogenes in liver cancer using an integrative
oncogenomic approach. Cell 125: 1253–1267.
16. Hall CA, Wang R, Miao J, Oliva E, Shen X, et al. (2010) Hippo pathway
effector Yap is an ovarian cancer oncogene. Cancer Res 70: 8517–8525.
17. Wang Y, Dong Q, Zhang Q, Li Z, Wang E, et al. (2010) Overexpression of yes-
associated protein contributes to progression and poor prognosis of non-small-
cell lung cancer. Cancer Sci 101(5): 1279–1285.
18. Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, et al. (2009) Yes-associated protein
is an independent prognostic marker in hepatocellular carcinoma. Cancer 115:
4576–4585.
19. Zhang X, George J, Deb S, Degoutin JL, Takano EA, et al. (2011) The Hippo
pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.
Oncogene 30: 2810–2822.
20. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent
gene induction and growth control. Genes Dev 22: 1962–1971.
21. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML (2001) TEAD/TEF
transcription factors utilize the activation domain of YAP65, a Src/Yes-
associated protein localized in the cytoplasm. Genes Dev 15: 1229–1241.
22. Ota M, Sasaki H (2008) Mammalian Tead proteins regulate cell proliferation
and contact inhibition as transcriptional mediators of Hippo signaling.
Development 135: 4059–4069.
23. Wu S, Liu Y, Zheng Y, Dong J, Pan D (2008) The TEAD/TEF family protein
Scalloped mediates transcriptional output of the Hippo growth-regulatory
pathway. Dev Cell 14: 388–398.
24. Zhang L, Ren F, Zhang Q, Chen Y, Wang B, et al. (2008) The TEAD/TEF
family of transcription factor Scalloped mediates Hippo signaling in organ size
control. Dev Cell 14: 377–387.
25. Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, et al. (2008)
SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-
suppressor pathway in Drosophila. Curr Biol 18: 435–441.
YAP: A Flexible Transcription Co-activator Protein
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e3199426. Sudol M, Harvey KF (2010) Modularity in the Hippo signaling pathway. Trends
Biochem Sci 35: 627–633.
27. Oka T, Sudol M (2009) Nuclear localization and pro-apoptotic signaling of
YAP2 require intact PDZ-binding motif. Genes Cells 14: 607–615.
28. Sudol M (1994) Yes-associated protein (YAP65) is a proline-rich phosphoprotein
that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9:
2145–2152.
29. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y (1999) A WW domain-
containing yes-associated protein (YAP) is a novel transcriptional co-activator.
Embo J 18: 2551–2562.
30. Hilman D, Gat U (2011) The Evolutionary history of YAP and the Hippo/YAP
pathway. Mol Biol Evol;doi: 10.1093/molbev/msr065.
31. Sebe ´-Pedro ´s A, Zheng Y, Ruiz-Trillo I, Pan D (2012) Premetazoan Origin of the
Hippo Signaling Pathway. Cell Reports 1: 1–8.
32. Lee T, Luo L (1999) Mosaic analysis with a repressible cell marker for studies of
gene function in neuronal morphogenesis. Neuron 22: 451–461.
33. Poon CL, Lin JI, Zhang X, Harvey KF (2011) The Sterile 20-like Kinase Tao-1
Controls Tissue Growth by Regulating the Salvador-Warts-Hippo Pathway. Dev
Cell 21: 896–906.
34. Grusche FA, Degoutin JL, Richardson HE, Harvey KF (2011) The Salvador/
Warts/Hippo pathway controls regenerative tissue growth in Drosophila
melanogaster. Dev Biol 350: 255–266.
35. Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, et al. (2008) Loss of
human Scribble cooperates with H-Ras to promote cell invasion through
deregulation of MAPK signalling. Oncogene 27: 5988–6001.
36. Chan SW, Lim CJ, Huang C, Chong YF, Gunaratne HJ, et al. (2011) WW
domain-mediated interaction with Wbp2 is important for the oncogenic
property of TAZ. Oncogene 30: 600–610.
37. Zhang X, Milton CC, Poon CL, Hong W, Harvey KF (2011) Wbp2 cooperates
with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo
pathway. Cell Death Differ 18: 1346–1355.
38. Oh H, Irvine KD (2011) Cooperative regulation of growth by Yorkie and Mad
through bantam. Dev Cell 20: 109–122.
YAP: A Flexible Transcription Co-activator Protein
PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31994